CTOR 8-K 2026-08-12

CITIUS ONCOLOGY, INC. (CTOR) 8-K dated 2026-08-12 — accession 0001213900-26-088068. This URL is the filing, not the CTOR hub.

CITIUS ONCOLOGY, INC. (CTOR) is a drug manufacturers - specialty & generic company listed on US.

CITIUS ONCOLOGY, INC. filed a 8-K on 2026-08-12. Accession 0001213900-26-088068.

Cached items: 5.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported CTOR revenue for 2026-06-30 was $7.1M. Net income was -$41.1M. Revenue was up 26.6% from 2026-03-31 to 2026-06-30. CTOR currently screens at market cap $105.2M.

Not investment advice. The CTOR SEC hub lists recent forms. The stock page is the research view.